We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...
Teva Pharmaceutical Industries Ltd. ADR-1.67% $19.92B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback